60 results on '"Gow P."'
Search Results
2. Outpatient continuous terlipressin infusion for hepatorenal syndrome is efficacious, safe and cost effective
3. Correlation of clinical stigmata to the severity of chronic liver disease
4. Community screening for cirrhosis using liver stiffness measurement – a pilot study
5. The TOSCAR study: sofosbuvir and daclatasvir therapy for decompensated HCV cirrhosis with MELD scores ≥ 15
6. An entecavir (ETV) and tenofovir (TDF) real world study – A retrospective review of long term entecavir and tenofovir therapy in chronic hepatitis B in Australia
7. Cancer registries underestimate hepatocellular carcinoma incidence: an independent population-based epidemiological study
8. Umbilical hernia repair is safe in patients with end stage liver disease
9. An objective immune function biomarker in cirrhotic patients and associated infection risk
10. High incidence of hepatocellular carcinoma in melbourne: Results from a population-based epidemiological study
11. Hepatocellular carcinoma can occur in non-alcoholic fatty liver disease without cirrhosis
12. Cardiac CT angiography is a feasible study in high-risk patients undergoing liver transplantation and can provide additional information to dobutamine stress echography
13. Differences in diagnosis and treatment outcome in sub-saharan african, south east asian and caucasian patients with hepatocellular carcinoma
14. Liver transplant outcomes in an aboriginal and torres strait islander population
15. Budd Chiari Syndrome (BCS): The Austin experience
16. Hepatobiliary and Pancreatic: Bleeding vaginal varices
17. Different definitions of HCV rapid fibrosis post liver transplant yield insights into the fibrosis timecourse
18. Changes in toll-like receptor 2 expression on peripheral immune cells in cirrhosis
19. Toll-like receptor 3 and 7/8 function is impaired in HCV patients with rapid fibrosis progression post liver transplantation
20. Role of co-factors for disease progression in hepatitis C patients referred for liver transplantation
21. Donor and recipient age and HLA-A mismatch: modifiable risk factors for rapid HCV recurrence post transplant
22. Toll-like receptor 7/8-induced type I interferon responses are impaired in hepatitis C patients with rapid fibrosis post liver transplant
23. Hepatitis B-related hepatocellular carcinoma is seen primarily in cirrhosis in an Australian cohort
24. Epidemiology of paracetamol overdose in Victoria over 7 years
25. Referrals to an intestinal transplantation centre in Australia—the early experience
26. Effects of liver transplant immunosuppressive agents on toll-like receptor 4 dependent innate immune responses
27. Transplantation trends in pbc in Australia and new zealand
28. Early versus late-onset non-anastomotic biliary strictures post liver transplant: risk factors reflect different pathogenesis?
29. Partial splenic embolisation for management of hypersplenism in patients with hepatitis C cirrhosis prior to antiviral therapy
30. Monocyte toll-like receptor (TLR) 2 and 4 expression in chronic hepatitis C (HCV) and during therapy with pegylated interferon and ribavirin
31. Non-anastomotic biliary strictures post liver transplantation are strongly associated with HLA-B and HLA-DR mismatch between donor and recipient
32. Effects of antibiotics on toll-like receptor (TLR) 2 and 4 expression on peripheral blood mononuclear cells (PBMC) and cytokine production in patients with decompensated cirrhosis
33. Down-regulation of the toll-like receptor (TLR) 4 dependant innate immune response protects against the development of acute allograft rejection in liver transplant recipients
34. Early single center results from the National Bowel Cancer Screening Program: a high rate of neoplasia detection
35. Variceal band ligation for primary prophylaxis of esophageal variceal hemorrhage in pre-liver transplant patients
36. Spontaneous bacterial peritonitis (SBP) prophylaxis: trimethoprim-sulfamethoxazole v norfloxacin
37. Role of polymorphisms in the angiotensin converting enzyme and endothelin-1 genes in post-liver transplant renal dysfunction: 148
38. Effect of SBP prophylaxis on Toll-like receptors 2 and 4 expression in patients with cirrhosis: 118
39. Outcome following acute upper gastrointestinal haemorrhage in a Melbourne teaching hospital 2005: 16
40. Is cirrhosis a risk factor for the development of peptic ulcer disease in the absence of Helicobacter pylori infection?: 215
41. Serum lactate has poor specificity in predicting death in paracetamol induced fulminant hepatic failure: 167
42. Does a fall in atmospheric pressure precipitate variceal bleeding?: 125
43. Radiologically inserted spleno-caval shunts for refractory portal hypertensive haemorrhage: 18
44. Efficacy and cost effectiveness of hepatoma screening at an Australian teaching hospital: 9
45. Terlipressin therapy for hepatorenal syndrome (HRS) – which patients should be treated?
46. Is transjugular intrahepatic portosystemic shunt (TIPSS) the treatment of in patients undergoing radiological intervention for Budd Chiari Syndrome?
47. Norfloxacin and Trimethoprim-sulfamethoxazole therapy have similar efficacy in the prevention of spontaneous bacterial peritonitis (SBP)
48. Fulminant hepatic failure due accidental paracetamol overdose
49. Epidemiology of PBC in Victoria, Australia. high prevalence in migrant populations
50. Efficacy and safety of conversion from calcineurin inhibitor (CNI) based immunosuppression to azathioprine (AZA) or mycophenolate mofetil (MMF) in liver transplant patients with renal impairment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.